16th Mar 2026 07:00
LEI: 549300Q7EXQQH6KF7Z84
16 March 2026
RTW Biotech Opportunities Ltd
Notice of 2025 Annual Results & Webinar
RTW Biotech Opportunities Ltd, the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to share that its Annual Results for the year ended 31 December 2025 will be published on Monday, 30 March 2026.
At 10:00 BST on that same day, RTW Investments' Chief Investment Officer, Rod Wong, and Senior Director of Business & Corporate Development, Oliver Kenyon, will host a webinar and Q&A via Investor Meet Company. The webinar is open to all existing and potential shareholders. Questions can be submitted via your Investor Meet Company dashboard up until 29 March 2026, or to [email protected] or at any time during the presentation.
Investors can sign up to Investor Meet Company for free and add to meet RTW Biotech Opportunities Ltd via: https://www.investormeetcompany.com/rtw-biotech-opportunities-ltd/register-investor
Investors who already follow RTW Bio on the Investor Meet Company platform will automatically be invited.
Enquiries:
RTW Investments, LP - Investment Manager Oliver Kenyon Krisha McCune (Investor Relations)
| +44 (0)20 7959 6362 |
Cadarn Capital - PR & IR Partner Lucy Clark (PR) David Harris (Distribution) |
+44 (0)7984 184 461 / [email protected] +44 (0)7368 883 211 / [email protected]
|
Deutsche Numis - Joint Corporate Broker Nathan Brown George Shiel Duncan Monteith
| +44 (0)20 7260 1000 |
BofA Securities - Joint Corporate Broker Edward Peel Alex Penney
| +44 (0)20 7628 1000 |
Altum (Guernsey) Limited Joanna Duquemin Nicolle Sadie Morrison
| +44 (0)1481 703 100 |
About RTW Biotech Opportunities Ltd:
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the website at www.rtwbio.com for more information.
***********
The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.
The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.
Related Shares:
Rtw Biotech